Shares of Semler Scientific Inc (OTCMKTS:SMLR) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $44.42 and traded as low as $40.06. Semler Scientific shares last traded at $41.00, with a volume of 7,716 shares traded.

Separately, ValuEngine downgraded shares of Semler Scientific from a “buy” rating to a “hold” rating in a research note on Wednesday, September 4th.

The business’s 50 day moving average is $47.22 and its 200 day moving average is $44.43. The stock has a market cap of $273.00 million, a price-to-earnings ratio of 62.05, a P/E/G ratio of 1.49 and a beta of 0.46.

Semler Scientific (OTCMKTS:SMLR) last issued its earnings results on Friday, July 26th. The medical equipment provider reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.10. Semler Scientific had a net margin of 27.91% and a return on equity of 155.19%. The firm had revenue of $7.95 million during the quarter, compared to the consensus estimate of $6.72 million. As a group, sell-side analysts expect that Semler Scientific Inc will post 1.13 earnings per share for the current year.

In other Semler Scientific news, Director Wayne T. Pan sold 600 shares of the company’s stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $51.16, for a total value of $30,696.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 14.10% of the company’s stock.

Semler Scientific Company Profile (OTCMKTS:SMLR)

Semler Scientific, Inc develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. Its products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Featured Story: Is a Roth IRA right for you?

Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with's FREE daily email newsletter.